Letter: S
Student LES-CCG
Suture Removal
Single Dose
Skin Cancer
SMI Health Checks
Safeguarding
Seafarers
Secondary Care Initiated Drugs
Secondary Care Investigations
Shared Care
Sigmoidoscopy
Shingles Vaccination Programme
Purpose and outline
In 2019 JCVI recommended the replacement of Zostavax with Shingrix and expansion of the cohorts in the Shingles Vaccination Programme. Replacement of Zostavax with the 2-dose Shingrix vaccine to the routine 70-79 year old cohort and a catch-up is being introduced for individuals from 65 years of age. Stocks of the Zostavax vaccine are still available and will therefore be used up before NHSE remove the relevant count from this service. For Shingrix, immunocompetent individuals will remain eligible until they attain the age of 80 years for first doses and 81 years for second doses. The changes also include the expansion of the immunocompromised cohort to include individuals aged 50 and over. There is no upper age limit for this cohort. The recommendations from JCVI will be implemented from September 2023. Practices are only paid for vaccinations carried out by the practice or sub-contracted by the practice, not for those given by other providers.
How this service is commissioned and provided
Region’s commission this service from GP practices.
NHS England service specifications
2023/24: Information about this service
- Quality service start date: 1 September 2023
- Quality service end date: 31 August 2024
- Payment period: Monthly
- Collection frequency: Monthly
- Manual or automatic entry: Automatic data collection
- Included in data collection: All system suppliers (TPP, Cegedim and Emis)
- System type: Vaccination and Immunisation (V&I )
Service user guides
The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.
Seasonal Influenza Vaccination Programme
Background
The seasonal flu programme is a long-established vaccination programme that is proven to save lives and deliver a cost-effective prevention programme. High levels of flu immunisation is one of the most effective interventions that can be made to reduce harm from flu and pressures on health and social care services during the winter. The annual immunisation programme is a critical element of the system-wide approach for delivering robust and resilient health and care services throughout the year, helping to reduce unplanned hospital admissions and pressure on A&E
Purpose and outline
The seasonal flu programme is a long-established vaccination programme that is proven to save lives and deliver a cost-effective prevention programme. High levels of flu immunisation is one of the most effective interventions that can be made to reduce harm from flu and pressures on health and social care services during the winter. The annual immunisation programme is a critical element of the system-wide approach for delivering robust and resilient health and care services throughout the year, helping to reduce unplanned hospital admissions and pressure on A&E. For 2023/24 seasonal flu will continue to allow vaccinations of both General Medical Service-registered (covers GMS, PMS and APMS practices) and INT-registered patients.
How this service is commissioned and provided
Region’s commission this service from GP practices.
2023/24: Information about this service
- Quality service start date: 01 September 2023
- Quality service end date: 31 March 2024
- Payment period: Monthly
- Collection frequency: Monthly
- Manual or automatic entry: Automatic data collection
- Included in data collection: All system suppliers (TPP, Cegedim and Emis)
- System type: Vaccination and Immunisation (V&I)
Service user guides
The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.